本页面由Tiger Trade Technology Pte. Ltd.提供服务

Talaris Therapeutics Inc.

12.08
0.0000
成交量:- -
成交额:83.75万
市值:517.24万
市盈率:-0.67
高:12.08
开:12.08
低:12.08
收:12.08
52周最高:32.90
52周最低:8.90
股本:42.81万
流通股本:19.34万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-17.9212
每股收益(LYR):-17.9144
净资产收益率:-41.64%
总资产收益率:-22.81%
市净率:0.03
市盈率(LYR):-0.67

数据加载中...

2023/10/31

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/20

重要事件披露

Form 8-K - Current report
2023/10/18

重要事件披露

Form 8-K - Current report
2023/10/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/10/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/10/10

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/07

重要事件披露

Form 8-K - Current report
2023/10/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/10/07

重要事件披露

Form 8-K - Current report
2023/09/26

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/14

SEC问询函

Form CORRESP - Correspondence
2023/09/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/12

SEC问询函

Form CORRESP - Correspondence